drugset / Trial / NCT00784693
A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether tanezumab is effective and safe in the treatment of pain associated with endometriosis.
Timeline
- Start
- 2008-12-18
- Primary completion
- 2010-01-27
- Completion
- 2010-04-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tanezumab | Monoclonal antibody | 15 mg | Intravenous |